Day: November 8, 2023

RadNet Reports Third Quarter Financial Results and Revises Upwards 2023 Financial Guidance Range for Adjusted EBITDA

Consolidated Revenue increased 14.8% to $402.0 million in the third quarter of 2023 from $350.0 million in the third quarter of 2022; Excluding Revenue from our Artificial Intelligence (“AI”) reporting segment, Revenue from the Imaging Centers reporting segment in the third quarter of 2023 was $399.1 million, an increase of 14.3% from last year’s third quarter of $349.1 million Excluding losses from our AI reporting segment, Adjusted EBITDA(1) from the Imaging Centers reporting segment was $60.4 million in the third quarter of 2023 as compared with $50.2 million in the third quarter of 2022, an increase of 20.3% After adjusting for certain unusual or one-time items impacting the quarters and AI pre-tax losses, Adjusted Earnings(3) was $9.9 million and diluted Adjusted Earnings Per Share(3) was $0.14 for the third quarter of 2023 as compared...

Continue reading

Agrify Receives Extended Stay of Suspension from Nasdaq

TROY, Mich., Nov. 08, 2023 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq: AGFY) (“Agrify”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on November 6, 2023 it received a letter from the Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that the stay of suspension for Agrify’s common stock will be extended until a hearing before the Panel and issuance of a final Panel decision. As previously reported, on October 17, 2023, Nasdaq staff notified Agrify (the “Staff Determination”) that it had initiated a process that could result in the delisting of Agrify’s securities from Nasdaq as a result of Agrify not being in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely...

Continue reading

Alimera Appoints Maggie A. Pax to Its Board of Directors

Maggie A. Pax Maggie A. Pax Appointed to Board of Directors of Alimera Sciences ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces the addition of Maggie A. Pax to its Board of Directors. Ms. Pax presently serves on the board of several life sciences companies. “Maggie’s experience within growing companies, leading product development, business strategy, supply chain, and commercial teams, along with leading the development of business partnerships, will bring additional operational experience to our board,” said Rick Eiswirth, Alimera’s President and Chief Executive Officer. “Her leadership in companies...

Continue reading

Intrepid Announces Third Quarter 2023 Results

Denver, CO, Nov. 08, 2023 (GLOBE NEWSWIRE) — Intrepid Potash, Inc. (“Intrepid”, the “Company”, “we”, “us”, “our”) (NYSE:IPI) today reported its results for the third quarter of 2023. Key Highlights for Third Quarter 2023 Financial & Operational Total sales of $54.5 million, which compares to $74.8 million in the third quarter of 2022, as potash and Trio® average net realized sales prices(1) decreased to $433 and $298 per ton, respectively. Net loss of $7.2 million (or $0.56 per diluted share), which compares to net income of $13.1 million (or $0.97 per diluted share) in the third quarter of 2022. Gross margin of $0.5 million, which compares to $26.8 million in the third quarter of 2022. Cash flow used in operations of $0.3 million, which compares to $14.1 million...

Continue reading

IO Biotech Announces Participation in Upcoming Investor Conferences

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, today announced its participation in the upcoming investor conferences: Event: Jefferies London Healthcare ConferenceLocation: LondonOne-on-one meetings: Wednesday, November 15, 2023Participants: Mai-Britt Zocca, PhD, President and CEO and Amy Sullivan, CFO Event: Piper Sandler 35th Healthcare ConferenceLocation: New York, New YorkFireside chat: Wednesday, November 29, 2023 at 4:30 pm ETPresenter: Mai-Britt Zocca, PhD, President & CEOWebcast link: https://event.webcasts.com/starthere.jsp?ei=1643140&tp_key=1d3631cba2 A webcast replay of the presentations will be available on IO Biotech’s website at www.iobiotech.com...

Continue reading

UMH PROPERTIES, INC. REPORTS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2023

FREEHOLD, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income for the quarter ended September 30, 2023 of $56.0 million, as compared to $51.9 million for the quarter ended September 30, 2022, representing an increase of 7.9%. Net Loss Attributable to Common Shareholders amounted to $5.8 million or $0.09 per diluted share for the quarter ended September 30, 2023, as compared to a Net Loss of $9.7 million or $0.18 per diluted share for the quarter ended September 30, 2022, representing a 100% per diluted share increase. Normalized Funds from Operations Attributable to Common Shareholders (“Normalized FFO”), was $14.4 million or $0.22 per diluted share for the quarter ended September 30, 2023, as compared to $13.1 million or $0.24 per diluted share for the quarter ended September 30,...

Continue reading

StoneX Group Inc. to Announce 2023 Fiscal Fourth Quarter Earnings on November 15, 2023

Conference call to follow on November 16, 2023 at 9:00am ET NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2023 fourth quarter results after the market close on Wednesday, November 15, 2023. Management will host a conference call on Thursday, November 16, 2023 at 9:00 a.m. Eastern Time to review the Company’s 2023 fiscal fourth quarter results. A live web cast of the conference call as well as additional information to review during the call will be made available in PDF form at https://www.stonex.com. Participants can also access the call via https://register.vevent.com/register/BIa273b443d0ab4ea585be27e0b2dcd79a approximately ten minutes prior to the start time. Participants may preregister for the conference call here. For those who cannot access...

Continue reading

Wesdome Announces Third Quarter 2023 Financial Results

TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO) (“Wesdome” or the “Company”) today announces third quarter (“Q3 2023”) financial results. Management will host a conference call tomorrow, Thursday November 9, 2023, at 10:00 a.m. Eastern time to discuss the results. Dial-in details for the call can be found near the end of this press release. Third Quarter 2023 Highlights Payable gold production in the third quarter was 27,760 ounces at cash costs per ounce1 of $1,755 (US$1,308) and all-in sustaining costs (“AISC”) per ounce 1 of $2,711 (US$2,021). Q3 was forecasted as the lightest cash flow quarter of the year due to timing of capital outlays and planned downtime at Eagle River. At Kiena, development of the ramp to the 129-level mining horizon tracked ahead of schedule. Delineation drilling to date...

Continue reading

Tandy Leather Factory Reports Third Quarter 2023 Results

FORT WORTH, TEXAS, Nov. 08, 2023 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the third fiscal quarter 2023, ended September 30, 2023. Third Quarter Highlights: Revenues were $17.5 million, down 8% from 2022 Generated operating income of $0.9 million Net income of $0.6 million Gross margins of 62.4% Adjusted EBITDA* of $1.4 million Ended quarter with $8.6 million of cash and cash equivalents Tandy Leather Factory’s third quarter sales were $17.5 million in 2023, down from $19.1 million in 2022. Third quarter 2023 gross profit was $10.9 million, down from $11.6 million in 2022. As of September 30, 2023, the Company held $8.6 million of cash and cash equivalents, up from $8.0 million at year end. The Company held inventory of $38.6 million, up from $38.2 million...

Continue reading

Prospect Capital Announces September 2023 Financial Results and Declares Steady Monthly Dividends through January 2024 of $0.06 Per Common Share

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended September 30, 2023. FINANCIAL RESULTS All amounts in $000’s except per share amounts (on weighted average basis for period numbers) Quarter Ended Quarter Ended Quarter Ended September 30, 2023 June 30, 2023 September 30, 2022         Net Investment Income (“NII”) $125,612 $112,779 $99,266 Basic NII per Common Share(1) $0.25 $0.23 $0.22 Interest as % of Total Investment Income 85.7% 89.1% 86.0% Basic NII Coverage of Distributions to Common Shareholders 139% 128% 122% Annualized Basic NII Return on Common NAV 10.8% 10.0% 8.8%         Net Income (Loss) Applicable to Common Shareholders $94,011 $(13,950) $(105,199) Basic Net Income...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.